We are live on
!
Find out more
LP
LMR Partners Portfolio holdings
AUM
$45.4B
1-Year Est. Return
60.68%
This Fund
S&P 500
This Quarter
Est. Return
+17.46%
1 Year Est. Return
+60.68%
3 Year Est. Return
+183.94%
5 Year Est. Return
+215.13%
10 Year Est. Return
+663.15%
AUM
$14B
AUM Growth
+$3.28B
(+31%)
Cap. Flow
+$324M
Cap. Flow
% of AUM
2.32%
Top 10 Holdings %
Top 10 Hldgs %
24.44%
Holding
1,743
New
418
Increased
280
Reduced
331
Closed
391
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares National Muni Bond ETF
MUB
|
+$176M |
| 2 |
Infosys
INFY
|
+$102M |
| 3 |
K
Kellanova
K
|
+$74.6M |
| 4 |
Amazon
AMZN
|
+$58.6M |
| 5 |
Alibaba
BABA
|
+$52.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
+$114M |
| 2 |
HDFC Bank
HDB
|
+$97.7M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$55.3M |
| 4 |
Roper Technologies
ROP
|
+$45.7M |
| 5 |
Nutanix
NTNX
|
+$44.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 10.38% |
| 2 | Financials | 4.13% |
| 3 | Consumer Discretionary | 2.33% |
| 4 | Communication Services | 2.26% |
| 5 | Healthcare | 2.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TIXT
726
DELISTED
TELUS International
TIXT
| $1.09M | 0.01% |
+300,000
| New | +$852K |
|
|
THRD
727
DELISTED
Third Harmonic Bio
THRD
| $1.09M | 0.01% |
+200,000
| New | +$997K |
|
728
PUT
SLB Ltd
SLB
$76.5B
| $1.08M | 0.01% |
32,100
-32,800
| -51% | -$1.14M |
|
729
Hershey
HSY
$36.6B
| $1.08M | 0.01% |
6,500
-2,025
| -24% | -$334K |
|
730
PUT
T-Mobile US
TMUS
$190B
| $1.07M | 0.01% |
4,500
-2,500
| -36% | -$610K |
|
731
Ally Financial
ALLY
$13.3B
| $1.07M | 0.01% |
+27,424
| New | +$950K |
|
732
Viatris
VTRS
$20.5B
| $1.07M | 0.01% |
+119,453
| New | +$1.01M |
|
|
EXAS
733
CALL
DELISTED
Exact Sciences
EXAS
| $1.06M | 0.01% |
20,000
-13,200
| -40% | -$671K |
|
734
Alphabet (Google) Class C
GOOG
$3.99T
| $1.05M | 0.01% |
+5,936
| New | +$981K |
|
735
Stanley Black & Decker
SWK
$14.6B
| $1.04M | 0.01% |
+15,416
| New | +$995K |
|
736
PUT
Target
TGT
$63.7B
| $1.04M | 0.01% |
10,500
-27,500
| -72% | -$2.64M |
|
737
PUT
Baker Hughes
BKR
$60.1B
| $1.04M | 0.01% |
27,000
| – | – |
|
738
CarMax
KMX
$8.29B
| $1.03M | 0.01% |
+15,380
| New | +$1.03M |
|
739
Verisk Analytics
VRSK
$27.1B
| $1.03M | 0.01% |
3,301
+527
| +19% | +$160K |
|
740
Paychex
PAYX
$41.1B
| $1.03M | 0.01% |
7,054
-431
| -6% | -$64.9K |
|
|
TAVI
741
Tavia Acquisition Corp
TAVI
$172M
| $1.02M | 0.01% |
100,000
| – | – |
|
742
Charter Communications
CHTR
$15.7B
| $1.02M | 0.01% |
2,500
+1,200
| +92% | +$459K |
|
743
CALL
MGM Resorts International
MGM
$11.8B
| $1.02M | 0.01% |
+29,700
| New | +$942K |
|
744
Credo Technology Group
CRDO
$38.8B
| $1.02M | 0.01% |
11,000
-26,680
| -71% | -$1.56M |
|
|
CHPGU
745
ChampionsGate Acquisition Corp Unit
CHPGU
| $1.02M | 0.01% |
+100,000
| New | +$1.01M |
|
746
Assurant
AIZ
$13.7B
| $1.01M | 0.01% |
+5,129
| New | +$1.01M |
|
747
EPAM Systems
EPAM
$4.92B
| $1M | 0.01% |
+5,672
| New | +$948K |
|
748
CALL
AngloGold Ashanti
AU
$40.7B
| $998K | 0.01% |
+21,900
| New | +$943K |
|
|
749
PUT
AngloGold Ashanti
AU
$40.7B
| $998K | 0.01% |
+21,900
| New | +$943K |
|
750
CALL
Hims & Hers Health
HIMS
$7B
| $997K | 0.01% |
+20,000
| New | +$904K |
|
Similar funds
AS
TI
LMR Partners's Q2 2025 Portfolio in Review
As of Q2 2025, LMR Partners held 1,743 positions worth $14B, up 31% from $10.7B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
LMR Partners's Q2 2025 filing shows 418 new, 280 increased, 331 reduced and 391 closed positions. Its largest new stake was Infosys: 5,733,005 shares worth $106M. The largest sale was Intra-Cellular Therapies Inc., an estimated $114M.
By sector, the portfolio is most concentrated in Technology at 10% of assets, down from 11% a quarter earlier, followed by Financials and Consumer Discretionary.
- LMR Partners's largest Q2 2025 buy was Infosys: 5,733,005 shares worth $106M.
- LMR Partners added most to iShares National Muni Bond ETF in Q2 2025, an estimated $176M increase.
- LMR Partners's biggest Q2 2025 reduction was Roper Technologies, cutting an estimated $45.7M.
- LMR Partners fully exited Intra-Cellular Therapies Inc. in Q2 2025, selling an estimated $114M.
- LMR Partners's ten largest holdings make up 24% of its $14B portfolio in Q2 2025.
- LMR Partners opened 418 new positions and closed 391 in Q2 2025.
- LMR Partners's portfolio value rose 31% quarter-over-quarter to $14B.
Based on LMR Partners's 13F filing for Q2 2025, filed 14 Aug 2025.